Global Non-invasive DNA Prenatal Testing Market Growth (Status and Outlook) 2026-2032
The global Non-invasive DNA Prenatal Testing market size is predicted to grow from US$ 722 million in 2025 to US$ 1541 million in 2032; it is expected to grow at a CAGR of 11.6% from 2026 to 2032.
Non-invasive DNA Prenatal Testing refers to a prenatal genetic assessment approach that analyzes fetal DNA signals present in a pregnant individual’s biological sample, most commonly a maternal blood sample, to estimate the risk of fetal genetic abnormalities without invasive sampling procedures. The method relies on laboratory analysis and computational interpretation of DNA fragments originating from the pregnancy, producing results that support clinical decision making about whether confirmatory diagnostic testing is needed and how to manage prenatal care. It is used as a screening tool rather than a definitive diagnosis, and its value depends on standardized sample handling, analytical accuracy, and responsible clinical interpretation within established prenatal counseling and follow-up workflows.
Non-invasive DNA Prenatal Testing is increasingly positioned as the default genetic risk assessment step in modern prenatal care because it offers a strong combination of patient safety, clinical utility, and operational scalability. From a research report perspective, market expansion is primarily driven by the continued shift from traditional screening toward DNA-based risk stratification, improving laboratory automation and bioinformatics, and broader clinical comfort with standardized reporting and follow-up pathways. Competitive differentiation is moving beyond basic aneuploidy screening toward performance in low fetal signal conditions, robust quality control, clear result interpretability for clinicians, and integrated service models that bundle pretest education and post-test counseling. At the same time, the market remains shaped by payer policy and regulation, which increasingly favor providers with strong clinical validation, transparent limitations, and consistent end-to-end execution across geographies and provider networks.
LPI (LP Information)' newest research report, the “Non-invasive DNA Prenatal Testing Industry Forecast” looks at past sales and reviews total world Non-invasive DNA Prenatal Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-invasive DNA Prenatal Testing sales for 2026 through 2032. With Non-invasive DNA Prenatal Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-invasive DNA Prenatal Testing industry.
This Insight Report provides a comprehensive analysis of the global Non-invasive DNA Prenatal Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-invasive DNA Prenatal Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-invasive DNA Prenatal Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-invasive DNA Prenatal Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-invasive DNA Prenatal Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-invasive DNA Prenatal Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Non-invasive DNA Prenatal Testing refers to a prenatal genetic assessment approach that analyzes fetal DNA signals present in a pregnant individual’s biological sample, most commonly a maternal blood sample, to estimate the risk of fetal genetic abnormalities without invasive sampling procedures. The method relies on laboratory analysis and computational interpretation of DNA fragments originating from the pregnancy, producing results that support clinical decision making about whether confirmatory diagnostic testing is needed and how to manage prenatal care. It is used as a screening tool rather than a definitive diagnosis, and its value depends on standardized sample handling, analytical accuracy, and responsible clinical interpretation within established prenatal counseling and follow-up workflows.
Non-invasive DNA Prenatal Testing is increasingly positioned as the default genetic risk assessment step in modern prenatal care because it offers a strong combination of patient safety, clinical utility, and operational scalability. From a research report perspective, market expansion is primarily driven by the continued shift from traditional screening toward DNA-based risk stratification, improving laboratory automation and bioinformatics, and broader clinical comfort with standardized reporting and follow-up pathways. Competitive differentiation is moving beyond basic aneuploidy screening toward performance in low fetal signal conditions, robust quality control, clear result interpretability for clinicians, and integrated service models that bundle pretest education and post-test counseling. At the same time, the market remains shaped by payer policy and regulation, which increasingly favor providers with strong clinical validation, transparent limitations, and consistent end-to-end execution across geographies and provider networks.
LPI (LP Information)' newest research report, the “Non-invasive DNA Prenatal Testing Industry Forecast” looks at past sales and reviews total world Non-invasive DNA Prenatal Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-invasive DNA Prenatal Testing sales for 2026 through 2032. With Non-invasive DNA Prenatal Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-invasive DNA Prenatal Testing industry.
This Insight Report provides a comprehensive analysis of the global Non-invasive DNA Prenatal Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-invasive DNA Prenatal Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-invasive DNA Prenatal Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-invasive DNA Prenatal Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-invasive DNA Prenatal Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-invasive DNA Prenatal Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Core Condition Screening
- Expanded Condition Screening
- Whole Genome Sequencing
- Targeted Sequencing
- Others
- Public Health Program
- Consumer
- Others
- Public Hospitals
- Private Hospitals
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Natera
- Labcorp
- Quest Diagnostics
- MedGenome
- Mayo Clinic Laboratories
- SYNLAB
- Myriad Genetics
- GGA
- Fulgent Genetics
- BillionToOne
- BGI Genomics
- Berry Genomics
- Annaroad
- Genesky
- Weihansi Biomedical Technology
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-invasive DNA Prenatal Testing Market Size (2021-2032)
2.1.2 Non-invasive DNA Prenatal Testing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Non-invasive DNA Prenatal Testing by Country/Region (2021, 2025 & 2032)
2.2 Non-invasive DNA Prenatal Testing Segment by Type
2.2.1 Equipment
2.2.2 Consumables
2.2.3 Non-invasive DNA Prenatal Testing Market Size by Type
2.2.3.1 Non-invasive DNA Prenatal Testing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
2.3 Non-invasive DNA Prenatal Testing Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Non-invasive DNA Prenatal Testing Market Size by Application
2.3.4.1 Non-invasive DNA Prenatal Testing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
3 NON-INVASIVE DNA PRENATAL TESTING MARKET SIZE BY PLAYER
3.1 Non-invasive DNA Prenatal Testing Market Size Market Share by Player
3.1.1 Global Non-invasive DNA Prenatal Testing Revenue by Player (2021-2026)
3.1.2 Global Non-invasive DNA Prenatal Testing Revenue Market Share by Player (2021-2026)
3.2 Global Non-invasive DNA Prenatal Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-INVASIVE DNA PRENATAL TESTING BY REGION
4.1 Non-invasive DNA Prenatal Testing Market Size by Region (2021-2026)
4.2 Global Non-invasive DNA Prenatal Testing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-invasive DNA Prenatal Testing Market Size Growth (2021-2026)
4.4 APAC Non-invasive DNA Prenatal Testing Market Size Growth (2021-2026)
4.5 Europe Non-invasive DNA Prenatal Testing Market Size Growth (2021-2026)
4.6 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Non-invasive DNA Prenatal Testing Market Size by Country (2021-2026)
5.2 Americas Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026)
5.3 Americas Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-invasive DNA Prenatal Testing Market Size by Region (2021-2026)
6.2 APAC Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026)
6.3 APAC Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-invasive DNA Prenatal Testing Market Size by Country (2021-2026)
7.2 Europe Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026)
7.3 Europe Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-invasive DNA Prenatal Testing by Region (2021-2026)
8.2 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026)
8.3 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-INVASIVE DNA PRENATAL TESTING MARKET FORECAST
10.1 Global Non-invasive DNA Prenatal Testing Forecast by Region (2027-2032)
10.1.1 Global Non-invasive DNA Prenatal Testing Forecast by Region (2027-2032)
10.1.2 Americas Non-invasive DNA Prenatal Testing Forecast
10.1.3 APAC Non-invasive DNA Prenatal Testing Forecast
10.1.4 Europe Non-invasive DNA Prenatal Testing Forecast
10.1.5 Middle East & Africa Non-invasive DNA Prenatal Testing Forecast
10.2 Americas Non-invasive DNA Prenatal Testing Forecast by Country (2027-2032)
10.2.1 United States Market Non-invasive DNA Prenatal Testing Forecast
10.2.2 Canada Market Non-invasive DNA Prenatal Testing Forecast
10.2.3 Mexico Market Non-invasive DNA Prenatal Testing Forecast
10.2.4 Brazil Market Non-invasive DNA Prenatal Testing Forecast
10.3 APAC Non-invasive DNA Prenatal Testing Forecast by Region (2027-2032)
10.3.1 China Non-invasive DNA Prenatal Testing Market Forecast
10.3.2 Japan Market Non-invasive DNA Prenatal Testing Forecast
10.3.3 Korea Market Non-invasive DNA Prenatal Testing Forecast
10.3.4 Southeast Asia Market Non-invasive DNA Prenatal Testing Forecast
10.3.5 India Market Non-invasive DNA Prenatal Testing Forecast
10.3.6 Australia Market Non-invasive DNA Prenatal Testing Forecast
10.4 Europe Non-invasive DNA Prenatal Testing Forecast by Country (2027-2032)
10.4.1 Germany Market Non-invasive DNA Prenatal Testing Forecast
10.4.2 France Market Non-invasive DNA Prenatal Testing Forecast
10.4.3 UK Market Non-invasive DNA Prenatal Testing Forecast
10.4.4 Italy Market Non-invasive DNA Prenatal Testing Forecast
10.4.5 Russia Market Non-invasive DNA Prenatal Testing Forecast
10.5 Middle East & Africa Non-invasive DNA Prenatal Testing Forecast by Region (2027-2032)
10.5.1 Egypt Market Non-invasive DNA Prenatal Testing Forecast
10.5.2 South Africa Market Non-invasive DNA Prenatal Testing Forecast
10.5.3 Israel Market Non-invasive DNA Prenatal Testing Forecast
10.5.4 Turkey Market Non-invasive DNA Prenatal Testing Forecast
10.6 Global Non-invasive DNA Prenatal Testing Forecast by Type (2027-2032)
10.7 Global Non-invasive DNA Prenatal Testing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Non-invasive DNA Prenatal Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Illumina
11.1.1 Illumina Company Information
11.1.2 Illumina Non-invasive DNA Prenatal Testing Product Offered
11.1.3 Illumina Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Illumina Main Business Overview
11.1.5 Illumina Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Non-invasive DNA Prenatal Testing Product Offered
11.2.3 Roche Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Natera
11.3.1 Natera Company Information
11.3.2 Natera Non-invasive DNA Prenatal Testing Product Offered
11.3.3 Natera Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Natera Main Business Overview
11.3.5 Natera Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Product Offered
11.4.3 Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 F. Hoffman-La Roche
11.5.1 F. Hoffman-La Roche Company Information
11.5.2 F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Product Offered
11.5.3 F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 F. Hoffman-La Roche Main Business Overview
11.5.5 F. Hoffman-La Roche Latest Developments
11.6 Pacific Biosciences Of California
11.6.1 Pacific Biosciences Of California Company Information
11.6.2 Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Product Offered
11.6.3 Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Pacific Biosciences Of California Main Business Overview
11.6.5 Pacific Biosciences Of California Latest Developments
11.7 Perkinelmer
11.7.1 Perkinelmer Company Information
11.7.2 Perkinelmer Non-invasive DNA Prenatal Testing Product Offered
11.7.3 Perkinelmer Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Perkinelmer Main Business Overview
11.7.5 Perkinelmer Latest Developments
11.8 LifeCodexx
11.8.1 LifeCodexx Company Information
11.8.2 LifeCodexx Non-invasive DNA Prenatal Testing Product Offered
11.8.3 LifeCodexx Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 LifeCodexx Main Business Overview
11.8.5 LifeCodexx Latest Developments
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Information
11.9.2 Agilent Technologies Non-invasive DNA Prenatal Testing Product Offered
11.9.3 Agilent Technologies Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Agilent Technologies Main Business Overview
11.9.5 Agilent Technologies Latest Developments
11.10 Labcorp
11.10.1 Labcorp Company Information
11.10.2 Labcorp Non-invasive DNA Prenatal Testing Product Offered
11.10.3 Labcorp Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Labcorp Main Business Overview
11.10.5 Labcorp Latest Developments
11.11 Mutiplicon
11.11.1 Mutiplicon Company Information
11.11.2 Mutiplicon Non-invasive DNA Prenatal Testing Product Offered
11.11.3 Mutiplicon Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Mutiplicon Main Business Overview
11.11.5 Mutiplicon Latest Developments
11.12 Premaitha Health
11.12.1 Premaitha Health Company Information
11.12.2 Premaitha Health Non-invasive DNA Prenatal Testing Product Offered
11.12.3 Premaitha Health Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Premaitha Health Main Business Overview
11.12.5 Premaitha Health Latest Developments
11.13 Beijing BGI
11.13.1 Beijing BGI Company Information
11.13.2 Beijing BGI Non-invasive DNA Prenatal Testing Product Offered
11.13.3 Beijing BGI Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Beijing BGI Main Business Overview
11.13.5 Beijing BGI Latest Developments
11.14 Berry Genomics
11.14.1 Berry Genomics Company Information
11.14.2 Berry Genomics Non-invasive DNA Prenatal Testing Product Offered
11.14.3 Berry Genomics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Berry Genomics Main Business Overview
11.14.5 Berry Genomics Latest Developments
11.15 Darui Biological
11.15.1 Darui Biological Company Information
11.15.2 Darui Biological Non-invasive DNA Prenatal Testing Product Offered
11.15.3 Darui Biological Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Darui Biological Main Business Overview
11.15.5 Darui Biological Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-invasive DNA Prenatal Testing Market Size (2021-2032)
2.1.2 Non-invasive DNA Prenatal Testing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Non-invasive DNA Prenatal Testing by Country/Region (2021, 2025 & 2032)
2.2 Non-invasive DNA Prenatal Testing Segment by Type
2.2.1 Equipment
2.2.2 Consumables
2.2.3 Non-invasive DNA Prenatal Testing Market Size by Type
2.2.3.1 Non-invasive DNA Prenatal Testing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
2.3 Non-invasive DNA Prenatal Testing Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Non-invasive DNA Prenatal Testing Market Size by Application
2.3.4.1 Non-invasive DNA Prenatal Testing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
3 NON-INVASIVE DNA PRENATAL TESTING MARKET SIZE BY PLAYER
3.1 Non-invasive DNA Prenatal Testing Market Size Market Share by Player
3.1.1 Global Non-invasive DNA Prenatal Testing Revenue by Player (2021-2026)
3.1.2 Global Non-invasive DNA Prenatal Testing Revenue Market Share by Player (2021-2026)
3.2 Global Non-invasive DNA Prenatal Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NON-INVASIVE DNA PRENATAL TESTING BY REGION
4.1 Non-invasive DNA Prenatal Testing Market Size by Region (2021-2026)
4.2 Global Non-invasive DNA Prenatal Testing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-invasive DNA Prenatal Testing Market Size Growth (2021-2026)
4.4 APAC Non-invasive DNA Prenatal Testing Market Size Growth (2021-2026)
4.5 Europe Non-invasive DNA Prenatal Testing Market Size Growth (2021-2026)
4.6 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Non-invasive DNA Prenatal Testing Market Size by Country (2021-2026)
5.2 Americas Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026)
5.3 Americas Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-invasive DNA Prenatal Testing Market Size by Region (2021-2026)
6.2 APAC Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026)
6.3 APAC Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Non-invasive DNA Prenatal Testing Market Size by Country (2021-2026)
7.2 Europe Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026)
7.3 Europe Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-invasive DNA Prenatal Testing by Region (2021-2026)
8.2 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026)
8.3 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NON-INVASIVE DNA PRENATAL TESTING MARKET FORECAST
10.1 Global Non-invasive DNA Prenatal Testing Forecast by Region (2027-2032)
10.1.1 Global Non-invasive DNA Prenatal Testing Forecast by Region (2027-2032)
10.1.2 Americas Non-invasive DNA Prenatal Testing Forecast
10.1.3 APAC Non-invasive DNA Prenatal Testing Forecast
10.1.4 Europe Non-invasive DNA Prenatal Testing Forecast
10.1.5 Middle East & Africa Non-invasive DNA Prenatal Testing Forecast
10.2 Americas Non-invasive DNA Prenatal Testing Forecast by Country (2027-2032)
10.2.1 United States Market Non-invasive DNA Prenatal Testing Forecast
10.2.2 Canada Market Non-invasive DNA Prenatal Testing Forecast
10.2.3 Mexico Market Non-invasive DNA Prenatal Testing Forecast
10.2.4 Brazil Market Non-invasive DNA Prenatal Testing Forecast
10.3 APAC Non-invasive DNA Prenatal Testing Forecast by Region (2027-2032)
10.3.1 China Non-invasive DNA Prenatal Testing Market Forecast
10.3.2 Japan Market Non-invasive DNA Prenatal Testing Forecast
10.3.3 Korea Market Non-invasive DNA Prenatal Testing Forecast
10.3.4 Southeast Asia Market Non-invasive DNA Prenatal Testing Forecast
10.3.5 India Market Non-invasive DNA Prenatal Testing Forecast
10.3.6 Australia Market Non-invasive DNA Prenatal Testing Forecast
10.4 Europe Non-invasive DNA Prenatal Testing Forecast by Country (2027-2032)
10.4.1 Germany Market Non-invasive DNA Prenatal Testing Forecast
10.4.2 France Market Non-invasive DNA Prenatal Testing Forecast
10.4.3 UK Market Non-invasive DNA Prenatal Testing Forecast
10.4.4 Italy Market Non-invasive DNA Prenatal Testing Forecast
10.4.5 Russia Market Non-invasive DNA Prenatal Testing Forecast
10.5 Middle East & Africa Non-invasive DNA Prenatal Testing Forecast by Region (2027-2032)
10.5.1 Egypt Market Non-invasive DNA Prenatal Testing Forecast
10.5.2 South Africa Market Non-invasive DNA Prenatal Testing Forecast
10.5.3 Israel Market Non-invasive DNA Prenatal Testing Forecast
10.5.4 Turkey Market Non-invasive DNA Prenatal Testing Forecast
10.6 Global Non-invasive DNA Prenatal Testing Forecast by Type (2027-2032)
10.7 Global Non-invasive DNA Prenatal Testing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Non-invasive DNA Prenatal Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Illumina
11.1.1 Illumina Company Information
11.1.2 Illumina Non-invasive DNA Prenatal Testing Product Offered
11.1.3 Illumina Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Illumina Main Business Overview
11.1.5 Illumina Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Non-invasive DNA Prenatal Testing Product Offered
11.2.3 Roche Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Natera
11.3.1 Natera Company Information
11.3.2 Natera Non-invasive DNA Prenatal Testing Product Offered
11.3.3 Natera Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Natera Main Business Overview
11.3.5 Natera Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Product Offered
11.4.3 Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 F. Hoffman-La Roche
11.5.1 F. Hoffman-La Roche Company Information
11.5.2 F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Product Offered
11.5.3 F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 F. Hoffman-La Roche Main Business Overview
11.5.5 F. Hoffman-La Roche Latest Developments
11.6 Pacific Biosciences Of California
11.6.1 Pacific Biosciences Of California Company Information
11.6.2 Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Product Offered
11.6.3 Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Pacific Biosciences Of California Main Business Overview
11.6.5 Pacific Biosciences Of California Latest Developments
11.7 Perkinelmer
11.7.1 Perkinelmer Company Information
11.7.2 Perkinelmer Non-invasive DNA Prenatal Testing Product Offered
11.7.3 Perkinelmer Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Perkinelmer Main Business Overview
11.7.5 Perkinelmer Latest Developments
11.8 LifeCodexx
11.8.1 LifeCodexx Company Information
11.8.2 LifeCodexx Non-invasive DNA Prenatal Testing Product Offered
11.8.3 LifeCodexx Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 LifeCodexx Main Business Overview
11.8.5 LifeCodexx Latest Developments
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Information
11.9.2 Agilent Technologies Non-invasive DNA Prenatal Testing Product Offered
11.9.3 Agilent Technologies Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Agilent Technologies Main Business Overview
11.9.5 Agilent Technologies Latest Developments
11.10 Labcorp
11.10.1 Labcorp Company Information
11.10.2 Labcorp Non-invasive DNA Prenatal Testing Product Offered
11.10.3 Labcorp Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Labcorp Main Business Overview
11.10.5 Labcorp Latest Developments
11.11 Mutiplicon
11.11.1 Mutiplicon Company Information
11.11.2 Mutiplicon Non-invasive DNA Prenatal Testing Product Offered
11.11.3 Mutiplicon Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Mutiplicon Main Business Overview
11.11.5 Mutiplicon Latest Developments
11.12 Premaitha Health
11.12.1 Premaitha Health Company Information
11.12.2 Premaitha Health Non-invasive DNA Prenatal Testing Product Offered
11.12.3 Premaitha Health Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Premaitha Health Main Business Overview
11.12.5 Premaitha Health Latest Developments
11.13 Beijing BGI
11.13.1 Beijing BGI Company Information
11.13.2 Beijing BGI Non-invasive DNA Prenatal Testing Product Offered
11.13.3 Beijing BGI Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Beijing BGI Main Business Overview
11.13.5 Beijing BGI Latest Developments
11.14 Berry Genomics
11.14.1 Berry Genomics Company Information
11.14.2 Berry Genomics Non-invasive DNA Prenatal Testing Product Offered
11.14.3 Berry Genomics Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Berry Genomics Main Business Overview
11.14.5 Berry Genomics Latest Developments
11.15 Darui Biological
11.15.1 Darui Biological Company Information
11.15.2 Darui Biological Non-invasive DNA Prenatal Testing Product Offered
11.15.3 Darui Biological Non-invasive DNA Prenatal Testing Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Darui Biological Main Business Overview
11.15.5 Darui Biological Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Non-invasive DNA Prenatal Testing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Non-invasive DNA Prenatal Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Equipment
Table 4. Major Players of Consumables
Table 5. Non-invasive DNA Prenatal Testing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
Table 8. Non-invasive DNA Prenatal Testing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
Table 11. Global Non-invasive DNA Prenatal Testing Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Non-invasive DNA Prenatal Testing Revenue Market Share by Player (2021-2026)
Table 13. Non-invasive DNA Prenatal Testing Key Players Head office and Products Offered
Table 14. Non-invasive DNA Prenatal Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Non-invasive DNA Prenatal Testing Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Region (2021-2026)
Table 19. Global Non-invasive DNA Prenatal Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Non-invasive DNA Prenatal Testing Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Non-invasive DNA Prenatal Testing Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Non-invasive DNA Prenatal Testing Market Size Market Share by Country (2021-2026)
Table 23. Americas Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
Table 25. Americas Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
Table 27. APAC Non-invasive DNA Prenatal Testing Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Non-invasive DNA Prenatal Testing Market Size Market Share by Region (2021-2026)
Table 29. APAC Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Non-invasive DNA Prenatal Testing Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Non-invasive DNA Prenatal Testing Market Size Market Share by Country (2021-2026)
Table 33. Europe Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Non-invasive DNA Prenatal Testing
Table 39. Key Market Challenges & Risks of Non-invasive DNA Prenatal Testing
Table 40. Key Industry Trends of Non-invasive DNA Prenatal Testing
Table 41. Global Non-invasive DNA Prenatal Testing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Non-invasive DNA Prenatal Testing Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Non-invasive DNA Prenatal Testing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Non-invasive DNA Prenatal Testing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Illumina Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 46. Illumina Non-invasive DNA Prenatal Testing Product Offered
Table 47. Illumina Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Illumina Main Business
Table 49. Illumina Latest Developments
Table 50. Roche Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 51. Roche Non-invasive DNA Prenatal Testing Product Offered
Table 52. Roche Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Roche Main Business
Table 54. Roche Latest Developments
Table 55. Natera Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 56. Natera Non-invasive DNA Prenatal Testing Product Offered
Table 57. Natera Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Natera Main Business
Table 59. Natera Latest Developments
Table 60. Thermo Fisher Scientific Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 61. Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Product Offered
Table 62. Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Thermo Fisher Scientific Main Business
Table 64. Thermo Fisher Scientific Latest Developments
Table 65. F. Hoffman-La Roche Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 66. F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Product Offered
Table 67. F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. F. Hoffman-La Roche Main Business
Table 69. F. Hoffman-La Roche Latest Developments
Table 70. Pacific Biosciences Of California Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 71. Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Product Offered
Table 72. Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Pacific Biosciences Of California Main Business
Table 74. Pacific Biosciences Of California Latest Developments
Table 75. Perkinelmer Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 76. Perkinelmer Non-invasive DNA Prenatal Testing Product Offered
Table 77. Perkinelmer Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Perkinelmer Main Business
Table 79. Perkinelmer Latest Developments
Table 80. LifeCodexx Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 81. LifeCodexx Non-invasive DNA Prenatal Testing Product Offered
Table 82. LifeCodexx Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. LifeCodexx Main Business
Table 84. LifeCodexx Latest Developments
Table 85. Agilent Technologies Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 86. Agilent Technologies Non-invasive DNA Prenatal Testing Product Offered
Table 87. Agilent Technologies Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Agilent Technologies Main Business
Table 89. Agilent Technologies Latest Developments
Table 90. Labcorp Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 91. Labcorp Non-invasive DNA Prenatal Testing Product Offered
Table 92. Labcorp Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Labcorp Main Business
Table 94. Labcorp Latest Developments
Table 95. Mutiplicon Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 96. Mutiplicon Non-invasive DNA Prenatal Testing Product Offered
Table 97. Mutiplicon Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Mutiplicon Main Business
Table 99. Mutiplicon Latest Developments
Table 100. Premaitha Health Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 101. Premaitha Health Non-invasive DNA Prenatal Testing Product Offered
Table 102. Premaitha Health Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Premaitha Health Main Business
Table 104. Premaitha Health Latest Developments
Table 105. Beijing BGI Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 106. Beijing BGI Non-invasive DNA Prenatal Testing Product Offered
Table 107. Beijing BGI Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Beijing BGI Main Business
Table 109. Beijing BGI Latest Developments
Table 110. Berry Genomics Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 111. Berry Genomics Non-invasive DNA Prenatal Testing Product Offered
Table 112. Berry Genomics Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Berry Genomics Main Business
Table 114. Berry Genomics Latest Developments
Table 115. Darui Biological Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 116. Darui Biological Non-invasive DNA Prenatal Testing Product Offered
Table 117. Darui Biological Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Darui Biological Main Business
Table 119. Darui Biological Latest Developments
Table 1. Non-invasive DNA Prenatal Testing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Non-invasive DNA Prenatal Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Equipment
Table 4. Major Players of Consumables
Table 5. Non-invasive DNA Prenatal Testing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
Table 8. Non-invasive DNA Prenatal Testing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
Table 11. Global Non-invasive DNA Prenatal Testing Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Non-invasive DNA Prenatal Testing Revenue Market Share by Player (2021-2026)
Table 13. Non-invasive DNA Prenatal Testing Key Players Head office and Products Offered
Table 14. Non-invasive DNA Prenatal Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Non-invasive DNA Prenatal Testing Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Region (2021-2026)
Table 19. Global Non-invasive DNA Prenatal Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Non-invasive DNA Prenatal Testing Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Non-invasive DNA Prenatal Testing Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Non-invasive DNA Prenatal Testing Market Size Market Share by Country (2021-2026)
Table 23. Americas Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
Table 25. Americas Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
Table 27. APAC Non-invasive DNA Prenatal Testing Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Non-invasive DNA Prenatal Testing Market Size Market Share by Region (2021-2026)
Table 29. APAC Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Non-invasive DNA Prenatal Testing Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Non-invasive DNA Prenatal Testing Market Size Market Share by Country (2021-2026)
Table 33. Europe Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Non-invasive DNA Prenatal Testing
Table 39. Key Market Challenges & Risks of Non-invasive DNA Prenatal Testing
Table 40. Key Industry Trends of Non-invasive DNA Prenatal Testing
Table 41. Global Non-invasive DNA Prenatal Testing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Non-invasive DNA Prenatal Testing Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Non-invasive DNA Prenatal Testing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Non-invasive DNA Prenatal Testing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Illumina Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 46. Illumina Non-invasive DNA Prenatal Testing Product Offered
Table 47. Illumina Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Illumina Main Business
Table 49. Illumina Latest Developments
Table 50. Roche Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 51. Roche Non-invasive DNA Prenatal Testing Product Offered
Table 52. Roche Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Roche Main Business
Table 54. Roche Latest Developments
Table 55. Natera Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 56. Natera Non-invasive DNA Prenatal Testing Product Offered
Table 57. Natera Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Natera Main Business
Table 59. Natera Latest Developments
Table 60. Thermo Fisher Scientific Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 61. Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Product Offered
Table 62. Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Thermo Fisher Scientific Main Business
Table 64. Thermo Fisher Scientific Latest Developments
Table 65. F. Hoffman-La Roche Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 66. F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Product Offered
Table 67. F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. F. Hoffman-La Roche Main Business
Table 69. F. Hoffman-La Roche Latest Developments
Table 70. Pacific Biosciences Of California Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 71. Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Product Offered
Table 72. Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Pacific Biosciences Of California Main Business
Table 74. Pacific Biosciences Of California Latest Developments
Table 75. Perkinelmer Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 76. Perkinelmer Non-invasive DNA Prenatal Testing Product Offered
Table 77. Perkinelmer Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Perkinelmer Main Business
Table 79. Perkinelmer Latest Developments
Table 80. LifeCodexx Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 81. LifeCodexx Non-invasive DNA Prenatal Testing Product Offered
Table 82. LifeCodexx Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. LifeCodexx Main Business
Table 84. LifeCodexx Latest Developments
Table 85. Agilent Technologies Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 86. Agilent Technologies Non-invasive DNA Prenatal Testing Product Offered
Table 87. Agilent Technologies Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Agilent Technologies Main Business
Table 89. Agilent Technologies Latest Developments
Table 90. Labcorp Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 91. Labcorp Non-invasive DNA Prenatal Testing Product Offered
Table 92. Labcorp Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Labcorp Main Business
Table 94. Labcorp Latest Developments
Table 95. Mutiplicon Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 96. Mutiplicon Non-invasive DNA Prenatal Testing Product Offered
Table 97. Mutiplicon Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Mutiplicon Main Business
Table 99. Mutiplicon Latest Developments
Table 100. Premaitha Health Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 101. Premaitha Health Non-invasive DNA Prenatal Testing Product Offered
Table 102. Premaitha Health Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Premaitha Health Main Business
Table 104. Premaitha Health Latest Developments
Table 105. Beijing BGI Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 106. Beijing BGI Non-invasive DNA Prenatal Testing Product Offered
Table 107. Beijing BGI Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Beijing BGI Main Business
Table 109. Beijing BGI Latest Developments
Table 110. Berry Genomics Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 111. Berry Genomics Non-invasive DNA Prenatal Testing Product Offered
Table 112. Berry Genomics Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Berry Genomics Main Business
Table 114. Berry Genomics Latest Developments
Table 115. Darui Biological Details, Company Type, Non-invasive DNA Prenatal Testing Area Served and Its Competitors
Table 116. Darui Biological Non-invasive DNA Prenatal Testing Product Offered
Table 117. Darui Biological Non-invasive DNA Prenatal Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Darui Biological Main Business
Table 119. Darui Biological Latest Developments
LIST OF FIGURES
Figure 1. Non-invasive DNA Prenatal Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-invasive DNA Prenatal Testing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Non-invasive DNA Prenatal Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Non-invasive DNA Prenatal Testing Sales Market Share by Country/Region (2025)
Figure 8. Non-invasive DNA Prenatal Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Type in 2025
Figure 10. Non-invasive DNA Prenatal Testing in Hospital
Figure 11. Global Non-invasive DNA Prenatal Testing Market: Hospital (2021-2026) & ($ millions)
Figure 12. Non-invasive DNA Prenatal Testing in Clinic
Figure 13. Global Non-invasive DNA Prenatal Testing Market: Clinic (2021-2026) & ($ millions)
Figure 14. Non-invasive DNA Prenatal Testing in Other
Figure 15. Global Non-invasive DNA Prenatal Testing Market: Other (2021-2026) & ($ millions)
Figure 16. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Application in 2025
Figure 17. Global Non-invasive DNA Prenatal Testing Revenue Market Share by Player in 2025
Figure 18. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Region (2021-2026)
Figure 19. Americas Non-invasive DNA Prenatal Testing Market Size 2021-2026 ($ millions)
Figure 20. APAC Non-invasive DNA Prenatal Testing Market Size 2021-2026 ($ millions)
Figure 21. Europe Non-invasive DNA Prenatal Testing Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size 2021-2026 ($ millions)
Figure 23. Americas Non-invasive DNA Prenatal Testing Value Market Share by Country in 2025
Figure 24. United States Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Non-invasive DNA Prenatal Testing Market Size Market Share by Region in 2025
Figure 29. APAC Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
Figure 30. APAC Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
Figure 31. China Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 35. India Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Non-invasive DNA Prenatal Testing Market Size Market Share by Country in 2025
Figure 38. Europe Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
Figure 39. Europe Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
Figure 40. Germany Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 41. France Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 54. APAC Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 55. Europe Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 57. United States Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 58. Canada Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 59. Mexico Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 60. Brazil Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 61. China Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 62. Japan Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 63. Korea Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 65. India Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 66. Australia Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 67. Germany Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 68. France Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 69. UK Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 70. Italy Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 71. Russia Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 72. Egypt Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 73. South Africa Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 74. Israel Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 75. Turkey Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 76. Global Non-invasive DNA Prenatal Testing Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Non-invasive DNA Prenatal Testing Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 1. Non-invasive DNA Prenatal Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Non-invasive DNA Prenatal Testing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Non-invasive DNA Prenatal Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Non-invasive DNA Prenatal Testing Sales Market Share by Country/Region (2025)
Figure 8. Non-invasive DNA Prenatal Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Type in 2025
Figure 10. Non-invasive DNA Prenatal Testing in Hospital
Figure 11. Global Non-invasive DNA Prenatal Testing Market: Hospital (2021-2026) & ($ millions)
Figure 12. Non-invasive DNA Prenatal Testing in Clinic
Figure 13. Global Non-invasive DNA Prenatal Testing Market: Clinic (2021-2026) & ($ millions)
Figure 14. Non-invasive DNA Prenatal Testing in Other
Figure 15. Global Non-invasive DNA Prenatal Testing Market: Other (2021-2026) & ($ millions)
Figure 16. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Application in 2025
Figure 17. Global Non-invasive DNA Prenatal Testing Revenue Market Share by Player in 2025
Figure 18. Global Non-invasive DNA Prenatal Testing Market Size Market Share by Region (2021-2026)
Figure 19. Americas Non-invasive DNA Prenatal Testing Market Size 2021-2026 ($ millions)
Figure 20. APAC Non-invasive DNA Prenatal Testing Market Size 2021-2026 ($ millions)
Figure 21. Europe Non-invasive DNA Prenatal Testing Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size 2021-2026 ($ millions)
Figure 23. Americas Non-invasive DNA Prenatal Testing Value Market Share by Country in 2025
Figure 24. United States Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Non-invasive DNA Prenatal Testing Market Size Market Share by Region in 2025
Figure 29. APAC Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
Figure 30. APAC Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
Figure 31. China Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 35. India Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Non-invasive DNA Prenatal Testing Market Size Market Share by Country in 2025
Figure 38. Europe Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
Figure 39. Europe Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
Figure 40. Germany Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 41. France Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Non-invasive DNA Prenatal Testing Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 54. APAC Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 55. Europe Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 57. United States Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 58. Canada Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 59. Mexico Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 60. Brazil Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 61. China Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 62. Japan Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 63. Korea Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 65. India Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 66. Australia Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 67. Germany Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 68. France Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 69. UK Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 70. Italy Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 71. Russia Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 72. Egypt Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 73. South Africa Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 74. Israel Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 75. Turkey Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
Figure 76. Global Non-invasive DNA Prenatal Testing Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Non-invasive DNA Prenatal Testing Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Non-invasive DNA Prenatal Testing Market Size 2027-2032 ($ millions)
